
Ademi LLP probes fairness of RXO's $5.8B sale to C.H. Robinson, questioning deal terms and board actions
RXO shareholders are set to receive $17.25 in cash plus 0.0856 shares of C.H. Robinson stock per RXO share in a $5.8 billion acquisition deal. Ademi LLP is investigating whether this offer fairly values RXO's shares, the benefits to company insiders,...

